Use the Search Fields to Find Information
Page 5 of 354
Vegetable oils composition affects the intestinal lymphatic transport and systemic bioavailability of co-administered lipophilic drug cannabidiol
Abstract Although natural sesame oil has been shown to facilitate the lymphatic delivery and oral bioavailability of the highly lipophilic drug cannabidiol (CBD), considerable
July 5, 2022
Vasoprotective Endothelial Effects of Chronic Cannabidiol Treatment and Its Influence on the Endocannabinoid System in Rats with Primary and Secondary Hypertension
Abstract Our study aimed to examine the endothelium (vascular)-protecting effects of chronic cannabidiol (CBD) administration (10 mg/kg once daily for 2 weeks) in aortas and
April 26, 2024
Vasodilatory effects of cannabidiol in human pulmonary and rat small mesenteric arteries: modification by hypertension and the potential pharmacological opportunities
Abstract Objective: Cannabidiol (CBD) has been suggested as a potential antihypertensive drug. The aim of our study was to investigate its vasodilatory effect in isolated
July 3, 2024
Vascular responses disrupted by fructose-induced hyperinsulinemia improved with delta-9- tetrahydrocannabinol
Abstract INTRODUCTION: In recent years, cannabinoids have been shown to have beneficial effects on diabetic vascular complications. Vascular complications due to fructose-induced hyperinsulinemia (HI)
May 20, 2024
Variation in the human cannabinoid receptor CNR1 gene modulates gaze duration for happy faces
Background: From an early age, humans look longer at preferred stimuli and also typically look longer at facial expressions of emotion, particularly happy faces. Atypical
September 19, 2019
Variability in Serum Concentrations and Clinical Response in Artisanal Versus Pharmaceutical Cannabidiol Treatment of Pediatric Pharmacoresistant Epilepsy
Abstract OBJECTIVE We hypothesized that serum cannabidiol (CBD) concentrations would be higher in patients taking pharmaceutical- versus artisanal-CBD oil, and higher serum CBD concentrations would
January 15, 2024
Varenicline as a treatment for cannabis use disorder: A placebo-controlled pilot trial
Please use this link to access this publication. ABSTRACT Background An efficacious pharmacotherapy for cannabis use disorder (CUD) has yet to be established. This study preliminarily evaluated
July 18, 2025
Vaporized cannabis extract–induced antinociception in male vs female rats with persistent inflammatory pain
Please use this link to access this publication: https://journals.lww.com/pain/abstract/2023/09000/vaporized_cannabis_extract_induced_antinociception.17.aspx Abstract Although preclinical studies generally report robust antinociceptive effects of cannabinoids in rodent persistent pain models, randomized
November 29, 2023
Vaping-Associated Acute Respiratory Failure Due to Acute Lipoid Pneumonia
Please use this link to access this publication. Abstract Electronic cigarettes, pens, cartridges and other devices were developed as nicotine delivery systems not requiring combustion
July 2, 2024
Vaping tetrahydrocannabinol unmasks Brugada pattern and induces ventricular fibrillation in Brugada syndrome: a case report
Abstract Background Fever, alcohol, and sodium channel blockers can unmask Brugada pattern and may also induce arrhythmias in Brugada syndrome. We report a case of
February 20, 2024
Page 5 of 354